Librería: Books Puddle, New York, NY, Estados Unidos de America
EUR 150,35
Cantidad disponible: 4 disponibles
Añadir al carritoCondición: New. pp. 170.
EUR 95,25
Cantidad disponible: 5 disponibles
Añadir al carritoTaschenbuch. Condición: Neu. Genotoxicity and Carcinogenicity Testing of Pharmaceuticals | Michael J. Graziano (u. a.) | Taschenbuch | x | Englisch | 2015 | Springer | EAN 9783319220833 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu.
Idioma: Inglés
Publicado por Springer, Springer International Publishing, 2015
ISBN 10: 3319220837 ISBN 13: 9783319220833
Librería: AHA-BUCH GmbH, Einbeck, Alemania
EUR 106,99
Cantidad disponible: 1 disponibles
Añadir al carritoTaschenbuch. Condición: Neu. Druck auf Anfrage Neuware - Printed after ordering - This book provides an overview of the nonclinical testing strategies that are used to asses and de-risk the genotoxicity and carcinogenicity properties of human pharmaceuticals. It includes a review of relevant ICH guidelines, numerous case studies where follow-up studies were conducted to further investigate positive findings, and practical considerations for the use of alternative and emerging tests. With contributions from recognized experts in the pharmaceutical industry and health authorities, this volume presents a balanced view on the interpretation and application of genotoxicity and carcinogenicity regulatory guidances. Genotoxicity and Carcinogenicity Testing of Pharmaceuticals is a valuable resource for scientists, regulators, and consultants that are engaged in the conduct, reporting, and review of nonclinical studies. This book will also help academicians better understand and appreciate the complexity of the regulations and breadth of toxicology research that are necessary to support the development and marketing of new drugs.
Librería: Revaluation Books, Exeter, Reino Unido
EUR 148,81
Cantidad disponible: 1 disponibles
Añadir al carritoPaperback. Condición: Brand New. 206 pages. 9.25x6.10x0.51 inches. In Stock.
Librería: Brook Bookstore On Demand, Napoli, NA, Italia
EUR 86,24
Cantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: new. Questo è un articolo print on demand.
Idioma: Inglés
Publicado por Springer International Publishing Nov 2015, 2015
ISBN 10: 3319220837 ISBN 13: 9783319220833
Librería: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Alemania
EUR 106,99
Cantidad disponible: 2 disponibles
Añadir al carritoTaschenbuch. Condición: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -This book provides an overview of the nonclinical testing strategies that are used to asses and de-risk the genotoxicity and carcinogenicity properties of human pharmaceuticals. It includes a review of relevant ICH guidelines, numerous case studies where follow-up studies were conducted to further investigate positive findings, and practical considerations for the use of alternative and emerging tests. With contributions from recognized experts in the pharmaceutical industry and health authorities, this volume presents a balanced view on the interpretation and application of genotoxicity and carcinogenicity regulatory guidances. Genotoxicity and Carcinogenicity Testing of Pharmaceuticals is a valuable resource for scientists, regulators, and consultants that are engaged in the conduct, reporting, and review of nonclinical studies. This book will also help academicians better understand and appreciate the complexity of the regulations and breadth of toxicology research that are necessary to support the development and marketing of new drugs. 216 pp. Englisch.
Idioma: Inglés
Publicado por Springer International Publishing, 2015
ISBN 10: 3319220837 ISBN 13: 9783319220833
Librería: moluna, Greven, Alemania
EUR 89,99
Cantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Provides context and real case studies to help address critical preclinical safety issues Provides an overview of alternative and emerging genotoxicity and carcinogenicity tests Written by well recognized experts in the pharmaceutical indus.
Librería: Majestic Books, Hounslow, Reino Unido
EUR 157,43
Cantidad disponible: 4 disponibles
Añadir al carritoCondición: New. Print on Demand pp. 170.
Librería: Biblios, Frankfurt am main, HESSE, Alemania
EUR 157,54
Cantidad disponible: 4 disponibles
Añadir al carritoCondición: New. PRINT ON DEMAND pp. 170.
Idioma: Inglés
Publicado por Springer, Palgrave Macmillan Nov 2015, 2015
ISBN 10: 3319220837 ISBN 13: 9783319220833
Librería: buchversandmimpf2000, Emtmannsberg, BAYE, Alemania
EUR 106,99
Cantidad disponible: 1 disponibles
Añadir al carritoTaschenbuch. Condición: Neu. This item is printed on demand - Print on Demand Titel. Neuware -This book provides an overview of the nonclinical testing strategies that are used to asses and de-risk the genotoxicity and carcinogenicity properties of human pharmaceuticals. It includes a review of relevant ICH guidelines, numerous case studies where follow-up studies were conducted to further investigate positive findings, and practical considerations for the use of alternative and emerging tests.With contributions from recognized experts in the pharmaceutical industry and health authorities, this volume presents a balanced view on the interpretation and application of genotoxicity and carcinogenicity regulatory guidances.Genotoxicity and Carcinogenicity Testing of Pharmaceuticals is a valuable resource for scientists, regulators, and consultants that are engaged in the conduct, reporting, and review of nonclinical studies. This book will also help academicians better understand and appreciate the complexity of the regulations and breadth of toxicology research that are necessary to support the development and marketing of new drugs.Springer-Verlag KG, Sachsenplatz 4-6, 1201 Wien 216 pp. Englisch.